Docoh
Loading...

7,421,517 results

Page 4 of 100
Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
6-K
BNTX BioNTech SE
25 Feb 21
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
6-K
IMRN Immuron Limited
25 Feb 21
Report of Foreign Private Issuer
8-K
CWH Camping World Holdings Inc
25 Feb 21
Results of Operations and Financial Condition
8-K
ITCI Intra-Cellular Therapies Inc
25 Feb 21
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2020 Financial Results and Provides Corporate Update
20-F
2020 FY
MDWD MediWound Ltd
25 Feb 21
Annual report (foreign)
8-K
EDIT Editas Medicine Inc
25 Feb 21
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
D
JO Fund I, a series of AngelList-GP-Funds-I, LP
25 Feb 21
$85.48K in investment fund, sold $85.48K, 22 investors
8-K
SHOO Steven Madden Ltd.
25 Feb 21
Results of Operations and Financial Condition
8-K
LAWS Lawson Products, Inc.
25 Feb 21
Lawson Products Reports Fourth Quarter and Full Year 2020 Results
8-K
PMTS CPI Card Group Inc.
25 Feb 21
CPI Card Group Inc. Announces Proposed Private Offering of $310 Million of Senior Secured Notes
10-K
2020 FY
ITCI Intra-Cellular Therapies Inc
25 Feb 21
Annual report
NPORT-P
Federated Core Trust III
25 Feb 21
Project and Trade Finance Core Fund f/k/a Federated Project and Trade Finance Core Fund (Dec 2020 report)
8-K
SAFM Sanderson Farms, Inc.
25 Feb 21
Sanderson Farms, Inc. Reports Results for First Quarter of Fiscal 2021
FWP
GROY Gold Royalty Corp.
25 Feb 21
Free writing prospectus
D
RI Fund I, a series of DV Collective, LP
25 Feb 21
$101.5K in investment fund, sold $101.5K, 29 investors
8-K
PLTK Playtika Holding Corp
25 Feb 21
Playtika Holding Corp. Reports Fourth Quarter 2020 Results
8-K
NTLA Intellia Therapeutics Inc
25 Feb 21
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
6-K
GSK Glaxosmithkline plc
25 Feb 21
GSK Announces Otilimab Data for Treatment of Covid
8-K
PLAN Anaplan Inc
25 Feb 21
Anaplan Announces Fourth Quarter and Full
10-K
2020 FY
PRVB Provention Bio Inc
25 Feb 21
Annual report